DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

GlaxoSmithKline (NYSE: GSK)

42.14 0.49 (1.18%)

REAL-TIME: Last trade at

Extended Hours: $42.50 $0.36 (0.85%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

GSK $42.14 1.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.22
Previous Close $41.65
Daily Range $41.95 - $42.36
52-Week Range $41.25 - $54.78
Market Cap $101.8B
P/E Ratio 14.31
Dividend (Yield) $2.31 (6.1%)
Ex-Dividend Date
Dividend Pay Date
05/13/15
07/09/15
Volume 2,926,298
Average Daily Volume 3,932,865
Current FY EPS $2.45

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

3 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend

GlaxoSmithKline is yielding nearly 6% on a trailing 12-month basis, but these three factors have the potential to dramatically cut its payout in the coming years.

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Best 3 Yielding Buy-Rated Stocks: VLY, LHO, GSK

Wall Street is Betting Big Against These 3 Biotechs

Biotech stocks have had a huge run recently, and now Wall Street is betting heavily against these 3 recent winners.

Vertex Pharma: Well Positioned To Set New Highs

Pre-Market Most Active for Jun 26, 2015 : MU, ALDR, GSK, SOHO, BP, NKE, AAPL, PVA, FB, CCL, ZTS, IN

Pre-Market Most Active for Jun 26, 2015 : MU, ALDR, GSK, SOHO, BP, NKE, AAPL, PVA, FB, CCL, ZTS, INTC

Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog

Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog

Pre-Market Most Active for Jun 25, 2015 : SEMI, GSK, CHK, TTHI, FB, STM, ERIC, SKM, AAPL, XIV, BAC,

Pre-Market Most Active for Jun 25, 2015 : SEMI, GSK, CHK, TTHI, FB, STM, ERIC, SKM, AAPL, XIV, BAC, FIT

Are These Heavily Shorted Biotech Stocks Good Contrarian Buys?

Short-sellers have piled into Adaptimmune Therapeutics and MannKind Corp. this year. Could these two biotechs represent good contrarian buys for the long-term investor?

Pre-Market Most Active for Jun 24, 2015 : SNR, NYLD, TERP, RDS/A, GSK, CORR, NOK, ADHD, CONE, NFLX,

Pre-Market Most Active for Jun 24, 2015 : SNR, NYLD, TERP, RDS/A, GSK, CORR, NOK, ADHD, CONE, NFLX, XIV, FB

See More GSK News...

GSK's Top Competitors

GSK $42.14 (1.18%)
Current stock: GSK
JNJ $98.47 (1.04%)
Current stock: JNJ
NVS $98.52 (0.18%)
Current stock: NVS
RHHBY $35.14 (0.20%)
Current stock: RHHBY